Pefloxacin Mesilate represents a high-purity active pharmaceutical ingredient classified within the fluoroquinolone antibiotic category. Manufactured to comply with international p...
Pefloxacin Mesilate represents a high-purity active pharmaceutical ingredient classified within the fluoroquinolone antibiotic category. Manufactured to comply with international pharmacopeial standards including IP, BP, EP, and USP grades, this API ensures adherence to global regulatory requirements for pharmaceutical production. Sourced from an FDA-approved facility with decades of industry experience, the product undergoes rigorous quality testing to guarantee consistent potency, stability, and safety profiles. Its chemical characteristics make it suitable for diverse dosage forms including tablets, capsules, and sterile injectable formulations, providing reliable antibacterial action against numerous pathogenic microorganisms.
Pharmaceutical manufacturers across human healthcare and veterinary medicine sectors utilize Pefloxacin Mesilate as a critical raw material for antibiotic production. Formulation scientists depend on this API when developing generic antibiotics, hospital injectables, and veterinary health products. The ingredient proves particularly valuable for companies producing broad-spectrum antibiotics targeting respiratory infections, urinary tract conditions, and gastrointestinal bacterial diseases. Industries prioritize this material for its consistent quality and compliance with Good Manufacturing Practice standards, ensuring finished products meet stringent safety and efficacy requirements for international markets while supporting animal health industries with effective treatment solutions.
Businesses selecting this Pefloxacin Mesilate supplier gain access to a dependable supply chain with demonstrated regulatory compliance and quality assurance protocols. The supplier's FDA certification and established market presence since 1971 provide exceptional reliability for procurement specialists requiring consistent API quality. The ready stock availability facilitates minimal lead times, supporting efficient manufacturing schedules and preventing production interruptions for pharmaceutical companies globally. This supply chain reliability translates into reduced manufacturing risks, streamlined production cycles, and enhanced end-product quality that meets international standards for safety and therapeutic effectiveness.
Key Features:
- Complies with IP, BP, EP, and USP pharmacopeial standards for global market access
- Available in injectable grade suitable for sterile formulation requirements
- Sourced from FDA-approved manufacturing facility ensuring regulatory compliance
- Ready stock availability enables prompt shipment and consistent supply chain
- Bulk quantities available with reliable delivery services since 1971
Benefits:
- Ensures global regulatory compliance through multiple pharmacopeial standards
- Supports sterile manufacturing processes with injectable grade availability
- Reduces regulatory risks through FDA-approved manufacturing source
- Minimizes production delays with ready stock and reliable delivery
- Provides supply chain confidence through established supplier track record